<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 6.3.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div><br>
  </div>
  <div>
    <div style="text-align: center; font-weight: bold;">As filed with the Securities and Exchange Commission on August 22, 2019.</div>
    <div><br>
    </div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-</div>
    <div style="text-align: center; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"><font style="font-size: 14pt;">UNITED STATES</font></div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C.&#160; 20549St</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 15%; color: #000000;"> </div>
    <div><br>
    </div>
    <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM S-8</div>
    <div style="text-align: center; font-weight: bold;">REGISTRATION STATEMENT</div>
    <div style="text-align: center; font-weight: bold;">UNDER</div>
    <div style="text-align: center; font-weight: bold;">THE SECURITIES ACT OF 1933</div>
    <div><br>
    </div>
    <div style="text-align: center; font-size: 24pt; font-weight: bold;">VIEMED HEALTHCARE, INC.</div>
    <div style="text-align: center;">(Exact name of registrant as specified in its charter)</div>
    <div style="text-align: center;"> <br>
    </div>
    <div style="text-align: center;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 15%; color: #000000;"> </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z1a677d955118479aa82886cb13fe23b3" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 33.33%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;">British Columbia, Canada</div>
            <div style="text-align: center;">(State or Other Jurisdiction</div>
            <div style="text-align: center;">of Incorporation or Organization)</div>
          </td>
          <td style="width: 33.33%; vertical-align: top;">&#160;</td>
          <td style="width: 33.33%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;">N/A</div>
            <div style="text-align: center;">(I.R.S. Employer</div>
            <div style="text-align: center;">Identification No.)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">202 N. Luke St.</div>
    <div style="text-align: center; font-weight: bold;">Lafayette, LA 70506</div>
    <div style="text-align: center;">(Address of Principal Executive Offices) (Zip Code)</div>
    <div style="text-align: center;"><br>
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 15%; color: #000000;"><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">AMENDED AND RESTATED VIEMED HEALTHCARE, INC. RESTRICTED SHARE UNIT AND DEFERRED SHARE UNIT PLAN</div>
    <div style="text-align: center;">(Full Title of the Plan)</div>
    <div style="text-align: center;"> <br>
    </div>
    <div style="text-align: center;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 15%; color: #000000;"> </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z2b65708f02af4312bafa0adf992b8951" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;" rowspan="1">
            <div style="text-align: center;">Name, Address and Telephone</div>
            <div style="text-align: center;">Number of Agent for Service:</div>
          </td>
          <td style="width: 50%; vertical-align: top; text-align: center;" rowspan="1">Copy of Communications to:</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 50%; vertical-align: top; text-align: center;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; text-align: center;" rowspan="1">
            <div style="font-weight: bold;">Trae Fitzgerald</div>
            <div style="font-weight: bold;">Chief Financial Officer</div>
            <div style="font-weight: bold;">Viemed Healthcare, Inc.</div>
            <div style="font-weight: bold;">202 N. Luke St.</div>
            <div style="font-weight: bold;">Lafayette, LA 70506</div>
            <div style="font-weight: bold;">&#160;(337) 504-3802</div>
          </td>
          <td style="width: 50%; vertical-align: top; text-align: center;" rowspan="1">
            <div style="font-weight: bold;">E. James Cowen</div>
            <div style="font-weight: bold;">Porter Hedges LLP</div>
            <div style="font-weight: bold;">1000 Main Street, 36<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
            <div style="font-weight: bold;">Houston, Texas 77002-6336</div>
            <div style="font-weight: bold;">(713) 226-6000</div>
            &#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 15%; color: #000000; text-align: center;"></div>
    <div><br>
    </div>
    <div style="text-indent: 27pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of &#8220;large accelerated
      filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z3a3f6548cb0f4dd6945f4bbfdf255a1d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 80%; vertical-align: top;">
            <div>Large accelerated filer &#9744;</div>
          </td>
          <td style="width: 20%; vertical-align: top;">
            <div>Accelerated filer &#9744;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z2cce96a047314810b928a6605e6e07bc" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 80%; vertical-align: top;">
            <div>Non-accelerated filer &#9744;&#160; (Do not check if a smaller reporting company)</div>
          </td>
          <td style="width: 20%; vertical-align: top;">
            <div>Smaller reporting company &#9746;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="ze67994056b4d46f8a2d1350f832c18f6" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 80%; vertical-align: top;">&#160;</td>
          <td style="width: 20%; vertical-align: top;">
            <div>Emerging growth company &#9746;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to
      Section 7(a)(2)(B) of the Securities Act. &#9744;</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z030a0b9c02944919a9586d7db4a73703">

        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: top; border-bottom: #000000 double 4px;" colspan="16">
            <div style="text-align: center; font-weight: bold;">CALCULATION OF REGISTRATION FEE</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 double 4px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;">Title of Securities to be Registered</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; font-weight: bold;">Amount to</div>
            <div> </div>
            <div style="text-align: center; font-weight: bold;">be Registered(1)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-weight: bold;">Proposed Maximum Offering</div>
            <div> </div>
            <div style="text-align: center; font-weight: bold;">Price per Share(2)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-weight: bold;">Proposed</div>
            <div> </div>
            <div style="text-align: center; font-weight: bold;">Maximum Aggregate</div>
            <div> </div>
            <div style="text-align: center; font-weight: bold;">Offering Price(2)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-weight: bold;">Amount of</div>
            <div> </div>
            <div style="text-align: center; font-weight: bold;">Registration Fee</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
            <div style="text-align: center;">Common Shares, no par value</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">5,832,191</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div>$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div>6.96</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div>$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div>40,592,049.36</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div>$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div>4,920</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>
        </tr>

    </table>
    <div>
      <div>
        <div> <br>
        </div>
        <table cellspacing="0" cellpadding="0" id="zf3eeb12ab8bc4822874757762233d9ed" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">(1)</td>
              <td style="width: auto; vertical-align: top;">
                <div>Pursuant to Rule 416(a), also registered hereunder is an indeterminate number of common shares issuable as a result of the anti-dilution provisions of the Amended and Restated Viemed Healthcare, Inc. Restricted Share Unit and Deferred
                  Share Unit Plan.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" id="za7b96c87a9d24d1fae332b3d29fa03f0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">(2)</td>
              <td style="width: auto; vertical-align: top;">
                <div>Pursuant to Rule 457(c), the registration fee is calculated on the basis of the average of the high and low sale prices for the common shares on the Nasdaq Capital Market on August 19, 2019, $6.96.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter"></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">PART I</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 24.5pt;">Viemed Healthcare, Inc. (the &#8220;Company&#8221;) prepared this Registration Statement in accordance with the requirements of Form S-8 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), to
      register an aggregate of 5,832,191 common shares of the Company that may be issued pursuant to the the Amended and Restated Viemed Healthcare, Inc. Restricted Share Unit and Deferred Share Unit Plan (the &#8220;Plan&#8221;). The documents containing the
      information specified in Part I of this Registration Statement will be sent or given to participants in the Plan, as specified by Rule 428(b)(1) promulgated under the Securities Act. Such documents need not be filed with the Securities and Exchange
      Commission (the &#8220;Commission&#8221;) either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 promulgated under the Securities Act. These documents and the documents incorporated by reference in this
      Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that meets the requirement of Section 10(a) of the Securities Act.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">PART II</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Item 3. Incorporation of Documents by Reference.</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">The following documents, which have previously been filed by the Company with the Commission under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), are incorporated herein by reference:</div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" id="zefd5aebfbe3a43949d311ddb7e07da24" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 42.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>The Company&#8217;s registration statement on <a href="http://www.sec.gov/Archives/edgar/data/1729149/000114036119012755/form1012b.htm">Form 10</a> (File No. 001-38973), filed with the Commission on July 10, 2019, as amended by <a href="http://www.sec.gov/Archives/edgar/data/1729149/000114036119014025/form1012ba.htm">Amendment No. 1 to Form 10</a>, filed with the Commission on August 1, 2019;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z1ea36e4e2636459d983af41304f67c5f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 42.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>The Company&#8217;s Quarterly Report on <a href="http://www.sec.gov/Archives/edgar/data/1729149/000172914919000005/q22019usgaap10-qdoc.htm">Form 10-Q</a> for the quarterly period ended June 30, 2019, filed with the Commission on August 9,
                  2019;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z3a00a62d77b346c99ee10fab43f02620" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 42.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>The Company&#8217;s Current Report on <a href="http://www.sec.gov/Archives/edgar/data/1729149/000114036119014661/form8k.htm">Form 8-K</a>, filed with the Commission on August 9, 2019 (excluding any information furnished pursuant to Item
                  2.02 or Item 7.01, or any corresponding information furnished under Item 9.01, of any such Current Report on Form 8-K); and</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z361663474fd34bde972f3d7911748320" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 42.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>The description of the common shares of the Company contained in the Company&#8217;s registration statement on <a href="http://www.sec.gov/Archives/edgar/data/1729149/000114036119012755/form1012b.htm">Form 10</a> (File No. 001-38973), filed
                  with the Commission on July 10, 2019, as amended by <a href="http://www.sec.gov/Archives/edgar/data/1729149/000114036119014025/form1012ba.htm">Amendment No. 1 to Form 10</a>, filed with the Commission on August 1, 2019, including any
                  amendment or report filed for purposes of updating such description.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">In addition, all documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (excluding any information furnished pursuant to Item 2.02 or Item 7.01, or any
      corresponding information furnished under Item 9.01, on any Current Report on Form 8-K) prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which
      deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents.&#160; Any statement contained in a document incorporated or
      deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document that also is or is deemed to
      be incorporated by reference herein, as the case may be, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration
      Statement.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Item 4. Description of Securities.</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">Not applicable.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Item 5. Interests of Named Experts and Counsel.</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">The validity of the issuance of the common shares will be passed upon for the Company by DLA Piper (Canada) LLP. As of August 21, 2019, certain attorneyss at DLA Piper (Canada) LLP owned 3,827 common shares of the
      Company and held options to purchase up to 40,000 common shares of the Company.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter"></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="font-weight: bold;">Item 6. Indemnification of Officers and Directors.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; color: #000000;">The <font style="font-style: italic;">Business Corporations Act</font> (British Columbia) (the &#8220;Business Corporations Act&#8221;) provides that:</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; margin-left: 0.1pt; color: #000000;">(1) The Company may indemnify an individual who: (i) is or was a director, alternate director or officer of the Company; (ii) is or was a director, alternate director or officer of
      another corporation: (A) at a time when such other corporation is or was an affiliate of the Company; or (B) at the request of the Company; or (iii) at the request of the Company, is or was, or holds or held a position equivalent to that of, a
      director, alternate director or officer of a partnership, trust, joint venture or other unincorporated entity, and his or her heirs and personal or other legal representatives of that individual (each such person referred to herein as an &#8220;eligible
      party&#8221;).</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; margin-left: 0.1pt; color: #000000;">(2) Such indemnity may provide for indemnification against any judgment, penalty, fine or settlement paid in respect of a proceeding in which such individual, by reason being or having
      been an eligible party is or may be joined as a party, or is or may be liable for provided, (a) he or she acted honestly and in good faith with a view to the best interests of the Company; and (b) in the case of a criminal or administrative action or
      proceeding that is enforced by a monetary penalty, he or she had reasonable grounds for believing that his or her conduct was lawful.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; margin-left: 0.1pt; color: #000000;">(3) If the Company declines to provide indemnification, a court may, on the application of the Company or an eligible party: (i) order the Company to indemnify an eligible party in the
      manner provided under (1); (ii) order the enforcement of, or any payment under, an agreement of indemnification entered into by the Company; or (iii) order the Company to pay some or all of the expenses incurred by any person in obtaining an order
      for indemnification under this item (3).</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; margin-left: 0.1pt; color: #000000;">(4) An eligible party is entitled to indemnity from the Company in respect of all costs, charges and expenses reasonably incurred by him or her in connection with the defence of any
      proceeding to which he or she is made a party by reason of being an eligible party, if the person seeking indemnity, (a) was substantially successful on the merits in his or her defence of the action or proceeding; and (b) fulfils the conditions set
      out in clauses (2)(a) and (b) above.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; margin-left: 0.1pt; color: #000000;">(5) The Company may purchase and maintain insurance for the benefit of an eligible party against any liability that may be incurred by reason of the eligible party being or having been
      a director or officer of, or holding or having held a position equivalent to that of a director or officer of, the Company or an associated corporation.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; margin-left: 0.1pt; color: #000000;">The Company&#8217;s notice of articles and articles (the &#8220;Articles&#8221;) provide that the Company must indemnify, to the extent allowed under the Business Corporations Act, each eligible party
      against all eligible penalties to which such person is or may be liable, and the Company must, after the final disposition of an eligible proceeding, pay the expenses actually and reasonably incurred by such person in respect of that proceeding. The
      Articles further provides that the Company may advance expenses to an eligible party to the extent permitted under the Business Corporations Act. The Articles also authorize the Company to obtain directors&#8217; and officers&#8217; liability insurance.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; margin-left: 0.1pt; color: #000000;">The Company maintains directors&#8217; and officers&#8217; liability insurance for its officers and directors.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; margin-left: 0.1pt; color: #000000;">Each director and officer is also a party to an indemnification agreement with the Company, pursuant to which the Company has agreed, to the fullest extent not prohibited by law and
      promptly upon demand, to indemnify and hold harmless such director or officer, his or her heirs and legal representatives from and against (i) all costs, charges and expenses incurred by such director or officer in respect of any claim, demand, suit,
      action, proceeding or investigation in which such director or officer is involved or is subject by reason of being or having been a director or officer and (ii) all liabilities, damages, costs, charges and expenses whatsoever that the director or
      officer may sustain or incur as a result of serving as a director or officer in respect of any act, matter, deed or thing whatsoever made, done, committed, permitted or acquiesced in by such director or officer in his or her capacity as a director or
      officer, whether before or after the effective date of such indemnification agreement.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter"></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="font-weight: bold;">Item 7. Exemption from Registration Claimed.</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">Not applicable.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Item 8. Exhibits.</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">See Index to Exhibits, attached hereto, which Index to Exhibits is hereby incorporated into this Item 8.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Item 9. Undertakings.</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">(a) The Company hereby undertakes:</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">(ii) To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate,
      represent a fundamental change in the information set forth in the Registration Statement; and</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">(iii) To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement.</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to
      the Commission by the Company pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the
      offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">&#160;(b) The Company hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Company&#8217;s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where
      applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the
      securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
    <div><br>
    </div>
    <div style="text-indent: 24.5pt;">(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the
      Company has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
      (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person
      in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
      by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter"></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this
      registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Lafayette, State of Louisiana, on this 22<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> day of August, 2019.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zf436be6ea1784023b742ad8e782f8790" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="2">
            <div style="font-weight: bold;">VIEMED HEALTHCARE, INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 37%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 37%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div>By:</div>
          </td>
          <td style="width: 37%; vertical-align: top; border-bottom: 2px solid black;">
            <div style="text-indent: 9pt;">/s/ Trae Fitzgerald</div>
          </td>
        </tr>
        <tr>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 37%; vertical-align: top;">
            <div style="text-indent: 9pt;">Trae Fitzgerald</div>
          </td>
        </tr>
        <tr>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 37%; vertical-align: top;">
            <div style="text-indent: 9pt;">Chief Financial Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;"><a name="POWEROFATTORNEY"><!--Anchor--></a><!--Anchor-->POWER OF ATTORNEY</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Casey Hoyt, W. Todd Zehnder and Trae Fitzgerald, and each of them, either of whom may act without joinder of the
      other, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any or all pre- and post-effective amendments and supplements to
      this registration statement, and to file the same, or cause to be filed the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto such attorneys-in-fact and agents,
      and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and
      confirming all that said attorneys-in-fact and agents, and each of them, or the substitute or substitutes of either of them, may lawfully do or cause to be done by virtue hereof.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.</div>
    <div style="text-indent: 36pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z8fb23d583ba34a4b85a48d2ca0235a91" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 31.15%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;"><u>Signature</u></div>
          </td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;"><u>Title</u></div>
          </td>
          <td style="width: 21.5%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;"><u>Date</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top;">&#160;</td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;">&#160;</td>
          <td style="width: 21.5%; vertical-align: top; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">/s/ Casey Hoyt</div>
          </td>
          <td style="width: 2.7%; vertical-align: top;" rowspan="2">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;" rowspan="2">
            <div>Chief Executive Officer and Director</div>
            <div>(Principal Executive Officer)</div>
          </td>
          <td style="width: 21.5%; vertical-align: top;" rowspan="2">
            <div style="text-align: center;">August 22, 2019</div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">Casey Hoyt</div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top;">&#160;</td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;">&#160;</td>
          <td style="width: 21.5%; vertical-align: top; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">/s/ Trae Fitzgerald</div>
          </td>
          <td style="width: 2.7%; vertical-align: top;" rowspan="2">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;" rowspan="3">
            <div>Chief Financial Officer</div>
            <div>(Principal Financial Officer and Accounting Officer)</div>
            <div>&#160;</div>
          </td>
          <td style="width: 21.5%; vertical-align: top;" rowspan="3">
            <div style="text-align: center;">
              <div>August 22, 2019</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-top: #000000 2px solid;" rowspan="2">
            <div style="text-align: center;">Trae Fitzgerald</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">/s/ W. Todd Zehnder</div>
          </td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;" rowspan="2">
            <div>Chief Operating Officer and Director</div>
          </td>
          <td style="width: 21.5%; vertical-align: top;" rowspan="2">
            <div style="text-align: center;">
              <div>August 22, 2019</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">W. Todd Zehnder</div>
          </td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top;">&#160;</td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;">&#160;</td>
          <td style="width: 21.5%; vertical-align: top; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">/s/ Randy Dobbs</div>
          </td>
          <td style="width: 2.7%; vertical-align: top;" rowspan="2">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;" rowspan="2">
            <div>Chairman of the Board</div>
          </td>
          <td style="width: 21.5%; vertical-align: top;" rowspan="2">
            <div style="text-align: center;">
              <div>August 22, 2019</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">Randy Dobbs</div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top;">&#160;</td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;">&#160;</td>
          <td style="width: 21.5%; vertical-align: top; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">/s/ Dr. William Frazier</div>
          </td>
          <td style="width: 2.7%; vertical-align: top;" rowspan="2">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;" rowspan="2">
            <div>Director and Chief Medical Officer</div>
          </td>
          <td style="width: 21.5%; vertical-align: top;" rowspan="2">
            <div style="text-align: center;">
              <div>August 22, 2019</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">Dr. William Frazier</div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top;">&#160;</td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;">&#160;</td>
          <td style="width: 21.5%; vertical-align: top; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">/s/ Bruce Greenstein</div>
          </td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;" rowspan="2">
            <div>Director</div>
          </td>
          <td style="width: 21.5%; vertical-align: top;" rowspan="2">
            <div style="text-align: center;">
              <div>August 22, 2019</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">Bruce Greenstein</div>
          </td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top;">&#160;</td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;">&#160;</td>
          <td style="width: 21.5%; vertical-align: top; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">/s/ Nitin Kaushal</div>
          </td>
          <td style="width: 2.7%; vertical-align: top;" rowspan="2">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;" rowspan="2">
            <div>Director</div>
          </td>
          <td style="width: 21.5%; vertical-align: top;" rowspan="2">
            <div style="text-align: center;">
              <div>August 22, 2019</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">Nitin Kaushal</div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top;">&#160;</td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;">&#160;</td>
          <td style="width: 21.5%; vertical-align: top; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">/s/ Timothy Smokoff</div>
          </td>
          <td style="width: 2.7%; vertical-align: top;" rowspan="2">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;" rowspan="2">
            <div>Director</div>
          </td>
          <td style="width: 21.5%; vertical-align: top;" rowspan="2">
            <div style="text-align: center;">
              <div>August 22, 2019</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">Timothy Smokoff</div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.15%; vertical-align: top;">&#160;</td>
          <td style="width: 2.7%; vertical-align: top;">&#160;</td>
          <td style="width: 44.65%; vertical-align: top;">&#160;</td>
          <td style="width: 21.5%; vertical-align: top; text-align: center;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter"></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">INDEX TO EXHIBITS</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zd09e1c4e3e5d43c4a7ec1ecefed9aed2" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 6%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;">Exhibit</div>
            <div style="text-align: center; font-weight: bold;">No.</div>
          </td>
          <td style="width: 3.24%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 91%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;">Description</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: right;"><a href="http://www.sec.gov/Archives/edgar/data/1729149/000114036119012755/ex10_7.htm">4.1</a></div>
          </td>
          <td style="width: 3.24%; vertical-align: top;">&#160;</td>
          <td style="width: 91%; vertical-align: top;">
            <div>Amended and Restated Viemed Healthcare, Inc. Restricted Share Unit and Deferred Share Unit Plan (incorporated herein by referene to Exhibit 10.7 to the Company&#8217;s registration statement on Form 10 (File No. 001-38973), filed with the
              Commission on July 10, 2019).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: right;"><a href="ex5_1.htm">*5.1</a></div>
          </td>
          <td style="width: 3.24%; vertical-align: top;">&#160;</td>
          <td style="width: 91%; vertical-align: top;">
            <div>Opinion of DLA Piper (Canada) LLP.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: right;"><a href="ex23_1.htm">*23.1</a></div>
          </td>
          <td style="width: 3.24%; vertical-align: top;">&#160;</td>
          <td style="width: 91%; vertical-align: top;">
            <div>Consent of MNP LLP.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: right;"><a href="ex5_1.htm">*23.2</a></div>
          </td>
          <td style="width: 3.24%; vertical-align: top;">&#160;</td>
          <td style="width: 91%; vertical-align: top;">
            <div>Consent of DLA Piper (Canada) LLP (included in Exhibit 5.1).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: right;"><a href="#POWEROFATTORNEY">*24.1</a></div>
          </td>
          <td style="width: 3.24%; vertical-align: top;">&#160;</td>
          <td style="width: 91%; vertical-align: top;">
            <div>Power of Attorney (included on signature page of this registration statement).</div>
          </td>
        </tr>

    </table>
    <div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
    </div>
    <div><br>
    </div>
    <div>*&#160; Filed herewith.</div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "forms8.htm", "description": "S-8", "secsgml_size_bytes": 56686}]
{"company-data": {"conformed-name": "VIEMED HEALTHCARE, INC.", "cik": "0001729149", "assigned-sic": "8090", "irs-number": "000000000", "state-of-incorporation": "A1", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-233411", "film-number": "191046528"}, "business-address": {"street1": "202 N. LUKE STREET", "city": "LAFAYETTE", "state": "LA", "zip": "70506", "phone": "337.504.3802"}, "mail-address": {"street1": "202 N. LUKE STREET", "city": "LAFAYETTE", "state": "LA", "zip": "70506"}}
As filed with the Securities and Exchange Commission on August 22, 2019.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549St
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
VIEMED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
British Columbia, Canada
(State or Other Jurisdiction
of Incorporation or Organization)
N/A
(I.R.S. Employer
Identification No.)
202 N. Luke St.
Lafayette, LA 70506
(Address of Principal Executive Offices) (Zip Code)
AMENDED AND RESTATED VIEMED HEALTHCARE, INC. RESTRICTED SHARE UNIT AND DEFERRED SHARE UNIT PLAN
(Full Title of the Plan)
Name, Address and Telephone
Number of Agent for Service:
Copy of Communications to:
Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
202 N. Luke St.
Lafayette, LA 70506
(337) 504-3802
E. James Cowen
Porter Hedges LLP
1000 Main Street, 36
th
Floor
Houston, Texas 77002-6336
(713) 226-6000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated
      filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer ☐
Accelerated filer ☐
Non-accelerated filer ☐  (Do not check if a smaller reporting company)
Smaller reporting company ☒
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to
      Section 7(a)(2)(B) of the Securities Act. ☐
CALCULATION OF REGISTRATION FEE
Title of Securities to be Registered
Amount to
be Registered(1)
Proposed Maximum Offering
Price per Share(2)
Proposed
Maximum Aggregate
Offering Price(2)
Amount of
Registration Fee
Common Shares, no par value
5,832,191
$
6.96
$
40,592,049.36
$
4,920
(1)
Pursuant to Rule 416(a), also registered hereunder is an indeterminate number of common shares issuable as a result of the anti-dilution provisions of the Amended and Restated Viemed Healthcare, Inc. Restricted Share Unit and Deferred
                  Share Unit Plan.
(2)
Pursuant to Rule 457(c), the registration fee is calculated on the basis of the average of the high and low sale prices for the common shares on the Nasdaq Capital Market on August 19, 2019, $6.96.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
Viemed Healthcare, Inc. (the "Company") prepared this Registration Statement in accordance with the requirements of Form S-8 under the Securities Act of 1933, as amended (the "Securities Act"), to
      register an aggregate of 5,832,191 common shares of the Company that may be issued pursuant to the the Amended and Restated Viemed Healthcare, Inc. Restricted Share Unit and Deferred Share Unit Plan (the "Plan"). The documents containing the
      information specified in Part I of this Registration Statement will be sent or given to participants in the Plan, as specified by Rule 428(b)(1) promulgated under the Securities Act. Such documents need not be filed with the Securities and Exchange
      Commission (the "Commission") either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 promulgated under the Securities Act. These documents and the documents incorporated by reference in this
      Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that meets the requirement of Section 10(a) of the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, which have previously been filed by the Company with the Commission under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), are incorporated herein by reference:
•
The Company's registration statement on
Form 10
(File No. 001-38973), filed with the Commission on July 10, 2019, as amended by
Amendment No. 1 to Form 10
, filed with the Commission on August 1, 2019;
•
The Company's Quarterly Report on
Form 10-Q
for the quarterly period ended June 30, 2019, filed with the Commission on August 9,
                  2019;
•
The Company's Current Report on
Form 8-K
, filed with the Commission on August 9, 2019 (excluding any information furnished pursuant to Item
                  2.02 or Item 7.01, or any corresponding information furnished under Item 9.01, of any such Current Report on Form 8-K); and
•
The description of the common shares of the Company contained in the Company's registration statement on
Form 10
(File No. 001-38973), filed
                  with the Commission on July 10, 2019, as amended by
Amendment No. 1 to Form 10
, filed with the Commission on August 1, 2019, including any
                  amendment or report filed for purposes of updating such description.
In addition, all documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (excluding any information furnished pursuant to Item 2.02 or Item 7.01, or any
      corresponding information furnished under Item 9.01, on any Current Report on Form 8-K) prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which
      deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents.  Any statement contained in a document incorporated or
      deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document that also is or is deemed to
      be incorporated by reference herein, as the case may be, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration
      Statement.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
The validity of the issuance of the common shares will be passed upon for the Company by DLA Piper (Canada) LLP. As of August 21, 2019, certain attorneyss at DLA Piper (Canada) LLP owned 3,827 common shares of the
      Company and held options to purchase up to 40,000 common shares of the Company.
Item 6. Indemnification of Officers and Directors.
The
Business Corporations Act
(British Columbia) (the "Business Corporations Act") provides that:
(1) The Company may indemnify an individual who: (i) is or was a director, alternate director or officer of the Company; (ii) is or was a director, alternate director or officer of
      another corporation: (A) at a time when such other corporation is or was an affiliate of the Company; or (B) at the request of the Company; or (iii) at the request of the Company, is or was, or holds or held a position equivalent to that of, a
      director, alternate director or officer of a partnership, trust, joint venture or other unincorporated entity, and his or her heirs and personal or other legal representatives of that individual (each such person referred to herein as an "eligible
      party").
(2) Such indemnity may provide for indemnification against any judgment, penalty, fine or settlement paid in respect of a proceeding in which such individual, by reason being or having
      been an eligible party is or may be joined as a party, or is or may be liable for provided, (a) he or she acted honestly and in good faith with a view to the best interests of the Company; and (b) in the case of a criminal or administrative action or
      proceeding that is enforced by a monetary penalty, he or she had reasonable grounds for believing that his or her conduct was lawful.
(3) If the Company declines to provide indemnification, a court may, on the application of the Company or an eligible party: (i) order the Company to indemnify an eligible party in the
      manner provided under (1); (ii) order the enforcement of, or any payment under, an agreement of indemnification entered into by the Company; or (iii) order the Company to pay some or all of the expenses incurred by any person in obtaining an order
      for indemnification under this item (3).
(4) An eligible party is entitled to indemnity from the Company in respect of all costs, charges and expenses reasonably incurred by him or her in connection with the defence of any
      proceeding to which he or she is made a party by reason of being an eligible party, if the person seeking indemnity, (a) was substantially successful on the merits in his or her defence of the action or proceeding; and (b) fulfils the conditions set
      out in clauses (2)(a) and (b) above.
(5) The Company may purchase and maintain insurance for the benefit of an eligible party against any liability that may be incurred by reason of the eligible party being or having been
      a director or officer of, or holding or having held a position equivalent to that of a director or officer of, the Company or an associated corporation.
The Company's notice of articles and articles (the "Articles") provide that the Company must indemnify, to the extent allowed under the Business Corporations Act, each eligible party
      against all eligible penalties to which such person is or may be liable, and the Company must, after the final disposition of an eligible proceeding, pay the expenses actually and reasonably incurred by such person in respect of that proceeding. The
      Articles further provides that the Company may advance expenses to an eligible party to the extent permitted under the Business Corporations Act. The Articles also authorize the Company to obtain directors' and officers' liability insurance.
The Company maintains directors' and officers' liability insurance for its officers and directors.
Each director and officer is also a party to an indemnification agreement with the Company, pursuant to which the Company has agreed, to the fullest extent not prohibited by law and
      promptly upon demand, to indemnify and hold harmless such director or officer, his or her heirs and legal representatives from and against (i) all costs, charges and expenses incurred by such director or officer in respect of any claim, demand, suit,
      action, proceeding or investigation in which such director or officer is involved or is subject by reason of being or having been a director or officer and (ii) all liabilities, damages, costs, charges and expenses whatsoever that the director or
      officer may sustain or incur as a result of serving as a director or officer in respect of any act, matter, deed or thing whatsoever made, done, committed, permitted or acquiesced in by such director or officer in his or her capacity as a director or
      officer, whether before or after the effective date of such indemnification agreement.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
See Index to Exhibits, attached hereto, which Index to Exhibits is hereby incorporated into this Item 8.
Item 9. Undertakings.
(a) The Company hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii) To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate,
      represent a fundamental change in the information set forth in the Registration Statement; and
(iii) To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement.
provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to
      the Commission by the Company pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.
(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the
      offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(b) The Company hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Company's annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where
      applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the
      securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the
      Company has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
      (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person
      in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
      by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this
      registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Lafayette, State of Louisiana, on this 22
nd
day of August, 2019.
VIEMED HEALTHCARE, INC.
By:
/s/ Trae Fitzgerald
Trae Fitzgerald
Chief Financial Officer
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Casey Hoyt, W. Todd Zehnder and Trae Fitzgerald, and each of them, either of whom may act without joinder of the
      other, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any or all pre- and post-effective amendments and supplements to
      this registration statement, and to file the same, or cause to be filed the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto such attorneys-in-fact and agents,
      and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and
      confirming all that said attorneys-in-fact and agents, and each of them, or the substitute or substitutes of either of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.
Signature
Title
Date
/s/ Casey Hoyt
Chief Executive Officer and Director
(Principal Executive Officer)
August 22, 2019
Casey Hoyt
/s/ Trae Fitzgerald
Chief Financial Officer
(Principal Financial Officer and Accounting Officer)
August 22, 2019
Trae Fitzgerald
/s/ W. Todd Zehnder
Chief Operating Officer and Director
August 22, 2019
W. Todd Zehnder
/s/ Randy Dobbs
Chairman of the Board
August 22, 2019
Randy Dobbs
/s/ Dr. William Frazier
Director and Chief Medical Officer
August 22, 2019
Dr. William Frazier
/s/ Bruce Greenstein
Director
August 22, 2019
Bruce Greenstein
/s/ Nitin Kaushal
Director
August 22, 2019
Nitin Kaushal
/s/ Timothy Smokoff
Director
August 22, 2019
Timothy Smokoff
INDEX TO EXHIBITS
Exhibit
No.
Description
4.1
Amended and Restated Viemed Healthcare, Inc. Restricted Share Unit and Deferred Share Unit Plan (incorporated herein by referene to Exhibit 10.7 to the Company's registration statement on Form 10 (File No. 001-38973), filed with the
              Commission on July 10, 2019).
*5.1
Opinion of DLA Piper (Canada) LLP.
*23.1
Consent of MNP LLP.
*23.2
Consent of DLA Piper (Canada) LLP (included in Exhibit 5.1).
*24.1
Power of Attorney (included on signature page of this registration statement).
*  Filed herewith.